# MOVING iMAGE TECHNOLOGIES INC.: financial statements, quarterly

MITQ · NYSE · CIK 1770236 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/mitq.md) · [Financials](/companies/mitq/financials.md) · [Filings](/companies/mitq/filings.md) · [Insiders](/companies/mitq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mitq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [6,635](/filings/0001558370-24-015610.md) | [3,265](/filings/0001770236-25-000008.md) | [3,890](/filings/0001770236-25-000021.md) | [6,349 d](/filings/0001558370-24-013066.md) | [5,252](/filings/0001558370-24-015610.md) | [3,441](/filings/0001770236-25-000008.md) | [3,571](/filings/0001770236-25-000021.md) | [5,883 d](/filings/0001437749-26-031299.md) | [5,582](/filings/0001437749-25-035100.md) | [3,793](/filings/0001437749-26-003868.md) | [3,397](/filings/0001437749-26-016903.md) | [4,546 d](/filings/0001437749-26-031299.md) |
| Cost of revenue | $k | [4,816](/filings/0001558370-24-015610.md) | [2,506](/filings/0001770236-25-000008.md) | [3,214](/filings/0001770236-25-000021.md) | [4,920 d](/filings/0001437749-25-029934.md) | [3,880](/filings/0001437749-25-035100.md) | [2,505](/filings/0001437749-26-003868.md) | [2,508](/filings/0001437749-26-016903.md) | [4,680 d](/filings/0001437749-26-031299.md) | [3,908](/filings/0001437749-25-035100.md) | [2,628](/filings/0001437749-26-003868.md) | [2,214](/filings/0001437749-26-016903.md) | [3,535 d](/filings/0001437749-26-031299.md) |
| Gross profit | $k | [1,819](/filings/0001558370-24-015610.md) | [759](/filings/0001770236-25-000008.md) | [676](/filings/0001770236-25-000021.md) | [1,429 d](/filings/0001437749-25-029934.md) | [1,372](/filings/0001437749-25-035100.md) | [936](/filings/0001437749-26-003868.md) | [1,063](/filings/0001437749-26-016903.md) | [1,203 d](/filings/0001437749-26-031299.md) | [1,674](/filings/0001437749-25-035100.md) | [1,165](/filings/0001437749-26-003868.md) | [1,183](/filings/0001437749-26-016903.md) | [1,011 d](/filings/0001437749-26-031299.md) |
| Research and development | $k | [67.0](/filings/0001558370-24-015610.md) | [72.0](/filings/0001770236-25-000008.md) | [73.0](/filings/0001770236-25-000021.md) | [65.0 d](/filings/0001437749-25-029934.md) | [61.0](/filings/0001437749-25-035100.md) | [47.0](/filings/0001437749-26-003868.md) | [49.0](/filings/0001437749-26-016903.md) | [46.0 d](/filings/0001437749-26-031299.md) | [48.0](/filings/0001437749-25-035100.md) | [47.0](/filings/0001437749-26-003868.md) | [45.0](/filings/0001437749-26-016903.md) | [46.0 d](/filings/0001437749-26-031299.md) |
| Operating income | $k | [384](/filings/0001558370-24-015610.md) | [(830)](/filings/0001770236-25-000008.md) | [(649)](/filings/0001770236-25-000021.md) | [(461) d](/filings/0001437749-25-029934.md) | [(68.0)](/filings/0001437749-25-035100.md) | [(561)](/filings/0001437749-26-003868.md) | [(270)](/filings/0001437749-26-016903.md) | [(187) d](/filings/0001437749-26-031299.md) | [350](/filings/0001437749-25-035100.md) | [(408)](/filings/0001437749-26-003868.md) | [(134)](/filings/0001437749-26-016903.md) | [(306) d](/filings/0001437749-26-031299.md) |
| Net income | $k | [439](/filings/0001770236-25-000021.md) | [(794)](/filings/0001770236-25-000021.md) | [(601)](/filings/0001770236-25-000021.md) | [(416) d](/filings/0001437749-25-029934.md) | [(25.0)](/filings/0001437749-26-016903.md) | [(527)](/filings/0001437749-26-016903.md) | [(240)](/filings/0001437749-26-016903.md) | [(156) d](/filings/0001437749-26-031299.md) | [509](/filings/0001437749-26-016903.md) | [(388)](/filings/0001437749-26-016903.md) | [(122)](/filings/0001437749-26-016903.md) | [(296) d](/filings/0001437749-26-031299.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001558370-24-015610.md) | [(0.07)](/filings/0001770236-25-000008.md) | [(0.06)](/filings/0001770236-25-000021.md) | not reported | [0.00](/filings/0001437749-25-035100.md) | [(0.05)](/filings/0001437749-26-003868.md) | [(0.02)](/filings/0001437749-26-016903.md) | not reported | [0.05](/filings/0001437749-25-035100.md) | [(0.04)](/filings/0001437749-26-003868.md) | [(0.01)](/filings/0001437749-26-016903.md) | not reported |
| Basic EPS | $ per share | [0.04](/filings/0001558370-24-015610.md) | [(0.07)](/filings/0001770236-25-000008.md) | [(0.06)](/filings/0001770236-25-000021.md) | not reported | [0.00](/filings/0001437749-25-035100.md) | [(0.05)](/filings/0001437749-26-003868.md) | [(0.02)](/filings/0001437749-26-016903.md) | not reported | [0.05](/filings/0001437749-25-035100.md) | [(0.04)](/filings/0001437749-26-003868.md) | [(0.01)](/filings/0001437749-26-016903.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.4](/filings/0001558370-23-018932.md) | [5.1](/filings/0001558370-24-001128.md) | [5.9](/filings/0001770236-24-000022.md) | [5.3](/filings/0001437749-25-029934.md) | [5.2](/filings/0001558370-24-015610.md) | [5.3](/filings/0001770236-25-000008.md) | [5.4](/filings/0001770236-25-000021.md) | [5.7](/filings/0001437749-26-031299.md) | [5.5](/filings/0001437749-25-035100.md) | [3.9](/filings/0001437749-26-003868.md) | [2.4](/filings/0001437749-26-016903.md) | [3.2](/filings/0001437749-26-031299.md) |
| Current assets | $m | [13.5](/filings/0001558370-23-018932.md) | [11.7](/filings/0001558370-24-001128.md) | [12.0](/filings/0001770236-24-000022.md) | [9.9](/filings/0001437749-25-029934.md) | [9.2](/filings/0001558370-24-015610.md) | [8.4](/filings/0001770236-25-000008.md) | [9.6](/filings/0001770236-25-000021.md) | [9.4](/filings/0001437749-26-031299.md) | [9.9](/filings/0001437749-25-035100.md) | [8.1](/filings/0001437749-26-003868.md) | [7.5](/filings/0001437749-26-016903.md) | [7.2](/filings/0001437749-26-031299.md) |
| Total assets | $m | [14.3](/filings/0001558370-23-018932.md) | [12.5](/filings/0001558370-24-001128.md) | [12.7](/filings/0001770236-24-000022.md) | [10.5](/filings/0001437749-25-029934.md) | [10.7](/filings/0001558370-24-015610.md) | [10.0](/filings/0001770236-25-000008.md) | [11.2](/filings/0001770236-25-000021.md) | [10.9](/filings/0001437749-26-031299.md) | [11.3](/filings/0001437749-25-035100.md) | [9.5](/filings/0001437749-26-003868.md) | [8.8](/filings/0001437749-26-016903.md) | [8.5](/filings/0001437749-26-031299.md) |
| Current liabilities | $m | [6.2](/filings/0001558370-23-018932.md) | [5.3](/filings/0001558370-24-001128.md) | [6.4](/filings/0001770236-24-000022.md) | [4.8](/filings/0001437749-25-029934.md) | [4.1](/filings/0001558370-24-015610.md) | [3.8](/filings/0001770236-25-000008.md) | [5.2](/filings/0001770236-25-000021.md) | [5.1](/filings/0001437749-26-031299.md) | [5.0](/filings/0001437749-25-035100.md) | [3.7](/filings/0001437749-26-003868.md) | [3.2](/filings/0001437749-26-016903.md) | [3.2](/filings/0001437749-26-031299.md) |
| Total liabilities | $m | [6.3](/filings/0001558370-23-018932.md) | [5.3](/filings/0001558370-24-001128.md) | [6.4](/filings/0001770236-24-000022.md) | [4.8](/filings/0001437749-25-029934.md) | [5.0](/filings/0001558370-24-015610.md) | [4.8](/filings/0001770236-25-000008.md) | [6.2](/filings/0001770236-25-000021.md) | [6.0](/filings/0001437749-26-031299.md) | [5.9](/filings/0001437749-25-035100.md) | [4.5](/filings/0001437749-26-003868.md) | [4.0](/filings/0001437749-26-016903.md) | [3.9](/filings/0001437749-26-031299.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [8.0](/filings/0001770236-25-000021.md) | [7.1](/filings/0001770236-25-000021.md) | [6.3](/filings/0001770236-25-000021.md) | [5.7](/filings/0001437749-26-031299.md) | [5.7](/filings/0001437749-26-016903.md) | [5.2](/filings/0001437749-26-016903.md) | [5.0](/filings/0001437749-26-016903.md) | [4.9](/filings/0001437749-26-031299.md) | [5.4](/filings/0001437749-26-016903.md) | [5.0](/filings/0001437749-26-016903.md) | [4.9](/filings/0001437749-26-016903.md) | [4.6](/filings/0001437749-26-031299.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(207)](/filings/0001558370-24-015610.md) | [(1,157) d](/filings/0001770236-25-000008.md) | [1,040 d](/filings/0001770236-25-000021.md) | [(472) d](/filings/0001437749-25-029934.md) | [(32.0)](/filings/0001437749-25-035100.md) | [70.0 d](/filings/0001437749-26-003868.md) | [53.0 d](/filings/0001437749-26-016903.md) | [346 d](/filings/0001437749-26-031299.md) | [(167)](/filings/0001437749-25-035100.md) | [(1,635) d](/filings/0001437749-26-003868.md) | [(1,499) d](/filings/0001437749-26-016903.md) | [834 d](/filings/0001437749-26-031299.md) |
| Capital expenditure | $k | [1.0](/filings/0001558370-24-015610.md) | [11.0 d](/filings/0001770236-25-000008.md) | [0.0 d](/filings/0001770236-25-000021.md) | [0.0 d](/filings/0001437749-25-029934.md) | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-031299.md) | not reported | not reported | not reported | [4.0 d](/filings/0001437749-26-031299.md) |
| Share repurchases | $k | not reported | not reported | [233 d](/filings/0001770236-25-000021.md) | [196 d](/filings/0001437749-25-029934.md) | not reported | not reported | not reported | [0.0 d](/filings/0001437749-25-029934.md) | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-031299.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.9](/filings/0001558370-23-018932.md) | [11.0](/filings/0001558370-24-001128.md) | [11.0](/filings/0001770236-24-000022.md) | [10.7](/filings/0001558370-24-015610.md) | [10.7](/filings/0001770236-25-000008.md) | [10.4](/filings/0001770236-25-000021.md) | [9.9](/filings/0001437749-25-035100.md) | [9.9](/filings/0001437749-26-003868.md) | [9.9](/filings/0001437749-26-016903.md) | [10.2](/filings/0001437749-25-035100.md) | [9.9](/filings/0001437749-26-003868.md) | [9.9](/filings/0001437749-26-016903.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,952,223 at 2026-09-28, from the cover of the [10-K filed 2026-09-28](/filings/0001437749-26-031299.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.